phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs001392.v1.p1 Natural History Study of SCID Disorders | Version 1: passed embargo
| VDAS | 30 | Longitudinal | | |
phs001194.v2.p2 Pediatric Cardiac Genomics Consortium (PCGC) Study | Versions 1-2: passed embargo
| VDAS | 9463 | Parent-Offspring Trios, Cohort | | HiSeq X Ten HiSeq 2000 xGen Exome Research Panel v1.0 SeqCap EZ Accessory Kit V2 SeqCap EZ MedExome Kit SureSelect Targeted Enrichment HumanOmni1-Quad BeadChip HumanOmni2.5-8v1_B HumanOmni2.5-8 (Omni2.5)
|
phs001326.v1.p1 A Retrospective and Cross-Sectional Analysis of Patients Treated for SCID Since January 1, 1968 | Version 1: passed embargo
| VDAS | 748 | Longitudinal, Observational, Cross-Sectional | | |
phs000093.v2.p2 A Genome Wide Scan of Lung Cancer and Smoking | Versions 1-2: passed embargo
| VDAS | 5566 | Case-Control, Cohort | Links | |
phs000774.v2.p1 CCDG: Genetics of Orofacial Clefts and Related Phenotypes | Versions 1-2: passed embargo
| VDAS | 11925 | Parent-Offspring, Nuclear Families, Extended Pedigrees | Links | Infinium HumanCore BeadChips 1000 Genomes
|
phs001232.v1.p1 Undiagnosed Diseases Network (UDN) | Version 1: passed embargo
| VDAS | 462 | Observational, Cross-Sectional, Parent-Offspring Trios | | VCRome 2.1 (HGSC design) HiSeq 2500 HiSeq X
|
phs000594.v1.p1 A Phase 2 Study of Tipifarnib in Large Granular Lymphocyte (LGL) Leukemia | Version 1: passed embargo
| VDAS | 9 | Interventional, Clinical Trial | Links | |
phs000187.v1.p1 High Density SNP Association Analysis of Melanoma | Version 1: passed embargo
| VDAS | 3115 | Case-Control, Case Set | Links | HumanOmni1-Quad_v1-0_B
|